• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

草药小柴胡汤(TJ-9)可预防胆碱缺乏的L-氨基酸限定饮食诱导的大鼠肝硬化中的肝纤维化和酶改变性病变。

Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.

作者信息

Sakaida I, Matsumura Y, Akiyama S, Hayashi K, Ishige A, Okita K

机构信息

First Department of Internal Medicine, School of Medicine, Yamaguchi University, Japan.

出版信息

J Hepatol. 1998 Feb;28(2):298-306. doi: 10.1016/0168-8278(88)80017-5.

DOI:10.1016/0168-8278(88)80017-5
PMID:9514543
Abstract

BACKGROUND/AIM: A herbal medicine, Sho-saiko-to (TJ-9), has recently been orally administered to patients with chronic liver disease in Japan and has been reported to inhibit the development of hepatocellular carcinoma. The aim of this study was to investigate whether TJ-9 has an inhibitory effect on the development of preneoplastic lesions and liver fibrosis in rats.

METHODS

The effects of the TJ-9 were examined using the choline-deficient L-amino acid-defined (CDAA) diet-induced liver fibrosis model in 16-week-old male Wistar rats.

RESULTS

TJ-9 (1% w/w) prevented fibrosis, as indicated by reduced hydroxyproline content in the liver and inhibition of the increase in a serum marker of fibrosis (hyaluronic acid), without reducing the increase in serum alanine aminotransferase and aspartate aminotransferase. TJ-9 also reduced the expression of type III procollagen alpha 1 mRNA in the liver, as well as the proliferation of myofibroblast-like cells (activated stellate cells, activated Ito cells). Furthermore, TJ-9 reduced the number of preneoplastic lesions, detected as enzyme-altered (glutathione S-transferase placental form-positive) lesions, in the liver.

CONCLUSIONS

These results indicate that the herbal medicine Sho-saiko-to (TJ-9) prevents fibrosis as well as preneoplastic lesions, not by inhibiting hepatocyte cell death but by inhibiting the activation of stellate cells, which are considered to be the main collagen-producing cells, leading to a reduction in the development of preneoplastic lesions.

摘要

背景/目的:一种草药制剂小柴胡汤(TJ - 9)最近在日本已被口服用于慢性肝病患者,并且有报道称其可抑制肝细胞癌的发生。本研究的目的是调查TJ - 9对大鼠癌前病变和肝纤维化的发展是否具有抑制作用。

方法

在16周龄雄性Wistar大鼠中,使用胆碱缺乏的L - 氨基酸限定(CDAA)饮食诱导的肝纤维化模型来检测TJ - 9的作用。

结果

TJ - 9(1% w/w)可预防纤维化,表现为肝脏中羟脯氨酸含量降低以及血清纤维化标志物(透明质酸)升高受到抑制,同时血清丙氨酸氨基转移酶和天冬氨酸氨基转移酶升高未受影响。TJ - 9还降低了肝脏中III型前胶原α1 mRNA的表达以及肌成纤维细胞样细胞(活化星状细胞、活化伊托细胞)的增殖。此外,TJ - 9减少了肝脏中作为酶改变(谷胱甘肽S - 转移酶胎盘型阳性)病变检测到的癌前病变数量。

结论

这些结果表明,草药制剂小柴胡汤(TJ - 9)可预防纤维化以及癌前病变,其机制不是通过抑制肝细胞死亡,而是通过抑制被认为是主要胶原产生细胞的星状细胞的活化,从而减少癌前病变的发展。

相似文献

1
Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.草药小柴胡汤(TJ-9)可预防胆碱缺乏的L-氨基酸限定饮食诱导的大鼠肝硬化中的肝纤维化和酶改变性病变。
J Hepatol. 1998 Feb;28(2):298-306. doi: 10.1016/0168-8278(88)80017-5.
2
Herbal medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.草药茵陈蒿汤(TJ - 135)可预防胆碱缺乏的L - 氨基酸限定饮食诱导的大鼠肝硬化中的肝纤维化和酶改变性病变。
J Hepatol. 2003 Jun;38(6):762-9. doi: 10.1016/s0168-8278(03)00094-1.
3
Extracellular matrix remodeling may predominate over hepatocyte injury in hepatocellular carcinoma development.在肝细胞癌发展过程中,细胞外基质重塑可能比肝细胞损伤更为突出。
Oncol Rep. 2003 Jul-Aug;10(4):957-62.
4
Iron chelator deferoxamine reduces preneoplastic lesions in liver induced by choline-deficient L-amino acid-defined diet in rats.铁螯合剂去铁胺可减少大鼠胆碱缺乏的L-氨基酸限定饮食诱导的肝脏癌前病变。
Dig Dis Sci. 1999 Mar;44(3):560-9. doi: 10.1023/a:1026661508553.
5
Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.吡格列酮可预防由胆碱缺乏的L-氨基酸限定饮食诱导的大鼠肝硬化中的肝脂肪变性、纤维化和酶改变性病变。
Biochem Biophys Res Commun. 2004 Feb 27;315(1):187-95. doi: 10.1016/j.bbrc.2004.01.038.
6
The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline-deficient L-amino acid-defined diet.脯氨酰4-羟化酶抑制剂HOE 077可防止肝星状细胞激活,降低由胆碱缺乏的L-氨基酸限定饮食诱导的大鼠肝纤维化中前胶原基因的表达。
Hepatology. 1996 Apr;23(4):755-63. doi: 10.1053/jhep.1996.v23.pm0008666329.
7
Fibrosis accelerates the development of enzyme-altered lesions in the rat liver.纤维化加速大鼠肝脏中酶改变性病变的发展。
Hepatology. 1998 Nov;28(5):1247-52. doi: 10.1002/hep.510280512.
8
Inhibitory effects of the herbal medicine Sho-saiko-to (TJ-9) on cell proliferation and procollagen gene expressions in cultured rat hepatic stellate cells.中药小柴胡汤(TJ-9)对培养的大鼠肝星状细胞增殖及前胶原基因表达的抑制作用。
J Hepatol. 1998 Oct;29(4):642-9. doi: 10.1016/s0168-8278(98)80161-x.
9
Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats.日本草药小柴胡汤对大鼠肝纤维化的影响。
Hepatology. 1999 Jan;29(1):149-60. doi: 10.1002/hep.510290108.
10
Herbal medicine Rhei rhizome prevents liver fibrosis in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.草药大黄根茎可预防由胆碱缺乏的L-氨基酸限定饮食诱导的大鼠肝硬化中的肝纤维化。
Life Sci. 2005 Apr 29;76(24):2805-16. doi: 10.1016/j.lfs.2004.09.041.

引用本文的文献

1
Multitargeted Herbal Prescription So Shiho Tang: A Scoping Review on Biomarkers for the Evaluation of Therapeutic Effects.多靶点中药复方柴胡四物汤:关于评估治疗效果生物标志物的范围综述
Pharmaceuticals (Basel). 2023 Sep 27;16(10):1371. doi: 10.3390/ph16101371.
2
Nanodrug rescues liver fibrosis via synergistic therapy with HO depletion and Saikosaponin b1 sustained release.纳米药物通过与 HO 耗竭和柴胡皂苷 b1 持续释放的协同治疗来挽救肝纤维化。
Commun Biol. 2023 Feb 16;6(1):184. doi: 10.1038/s42003-023-04473-2.
3
Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma.
基于系统药理学的方法研究软肝利胆汤治疗肝癌的作用机制。
Comput Math Methods Med. 2022 Dec 17;2022:2940654. doi: 10.1155/2022/2940654. eCollection 2022.
4
Translational research in anti-pancreatic fibrosis drug discovery and development.抗胰腺纤维化药物研发中的转化研究。
J Transl Int Med. 2021 Dec 31;9(4):225-227. doi: 10.2478/jtim-2021-0036. eCollection 2021 Dec 1.
5
Traditional Chinese Medicine Alleviated Experimental Hepatic Damage by Inhibiting Oxidation, Inflammation, and Apoptosis in Cell and Mouse Models.中药通过抑制细胞和小鼠模型中的氧化、炎症和凋亡减轻实验性肝损伤。
Evid Based Complement Alternat Med. 2021 Oct 5;2021:2556352. doi: 10.1155/2021/2556352. eCollection 2021.
6
Changes in hepatic metabolic profile during the evolution of STZ-induced diabetic rats via an H NMR-based metabonomic investigation.基于~1H NMR 的代谢组学研究 STZ 诱导的糖尿病大鼠在病程进展中肝代谢谱的变化。
Biosci Rep. 2019 Apr 23;39(4). doi: 10.1042/BSR20181379. Print 2019 Apr 30.
7
The Inhibition of Indoleamine 2,3-Dioxygenase Accelerates Early Liver Regeneration in Mice After Partial Hepatectomy.吲哚胺2,3-双加氧酶的抑制作用可加速小鼠部分肝切除术后的早期肝脏再生。
Dig Dis Sci. 2017 Sep;62(9):2386-2396. doi: 10.1007/s10620-017-4651-6. Epub 2017 Jun 21.
8
Prescription frequency and patterns of Chinese herbal medicine for liver cancer patients in Taiwan: a cross-sectional analysis of the National Health Insurance Research Database.台湾肝癌患者的中药处方频率及模式:基于全民健康保险研究数据库的横断面分析
BMC Complement Altern Med. 2017 Feb 20;17(1):118. doi: 10.1186/s12906-017-1628-0.
9
The Deficiency of Indoleamine 2,3-Dioxygenase Aggravates the CCl4-Induced Liver Fibrosis in Mice.吲哚胺2,3-双加氧酶缺乏加重小鼠四氯化碳诱导的肝纤维化
PLoS One. 2016 Sep 6;11(9):e0162183. doi: 10.1371/journal.pone.0162183. eCollection 2016.
10
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step.保肝和抗纤维化药物:是时候迈出下一步了。
Front Pharmacol. 2016 Jan 7;6:303. doi: 10.3389/fphar.2015.00303. eCollection 2015.